Skip to content
2000
Volume 28, Issue 6
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Identification of patients with antibody-mediated encephalitis poses a diagnostic challenge, and any delay in that aspect will increase the interval until the initiation of immunotherapy and may negatively affect the patient´s clinical outcome. Within this review, we focus on therapeutic strategies in antibody-mediated encephalitis and propose how to proceed with patients who are suspected of having encephalitis of unknown origin. We further briefly outline differences in the treatment of paraneoplastic and antibody-mediated encephalitis according to its pathomechanisms.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612828666220131093259
2022-02-01
2025-07-04
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612828666220131093259
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test